TY  - CHAP
AU  - J.A. Junco
AU  - F. Fuentes
AU  - R. Basulto
AU  - E. Bover
AU  - M.D. Castro
AU  - E. Pimentel
AU  - O. Reyes
AU  - R. Bringas
AU  - L. Calzada
AU  - Y. López
AU  - N. Arteaga
AU  - A. Rodríguez
AU  - H. Garay
AU  - R. Rodríguez
AU  - L. González-Quiza
AU  - L. Fong
AU  - G.E. Guillén
ED  - Hilal Arnouk
Y1  - 2012-02-03
PY  - 2012
T1  - Prostate Cancer Immunotherapy – Strategy with a Synthetic GnRH Based Vaccine Candidate
N2  - Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical researchers have joined forces to collaborate and review current developments and trends in cancer immunology for the purposes of this book, and the result is a promising review of contemporary clinical treatments. In each chapter the authors present the scientific basis behind such therapeutic approaches, including cancer vaccines with special focus on prostate cancer, melanoma and novel approaches utilizing both innate and adaptive immune responses.
BT  - Advancements in Tumor Immunotherapy and Cancer Vaccines
SP  - Ch. 4
UR  - https://doi.org/10.5772/27191
DO  - 10.5772/27191
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-25
ER  -